233 related articles for article (PubMed ID: 9785332)
21. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
23. [Anemia in lung cancer patients].
Méric JB; Morère JF;
Bull Cancer; 2005 May; 92(5):439-44. PubMed ID: 15932807
[TBL] [Abstract][Full Text] [Related]
24. Treating anemia in patients with cancer.
Tecnologica; 2001 Oct; ():1, 3-8. PubMed ID: 11776275
[No Abstract] [Full Text] [Related]
25. [Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX; Meng FJ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
[No Abstract] [Full Text] [Related]
26. Contribution of anemia to fatigue in the cancer patient.
Sabbatini P
Oncology (Williston Park); 2000 Nov; 14(11A):69-71. PubMed ID: 11195421
[TBL] [Abstract][Full Text] [Related]
27. [The role of erythropoietin].
Godin M
Soins; 2004 Sep; (688 Suppl):5. PubMed ID: 15526820
[No Abstract] [Full Text] [Related]
28. Interventions for anemia in pediatric cancer patients.
Ruggiero A; Riccardi R
Med Pediatr Oncol; 2002 Oct; 39(4):451-4. PubMed ID: 12203662
[TBL] [Abstract][Full Text] [Related]
29. [Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
Queipo Zaragozá JA; Chicote Pérez F; Beltrán Meseguer JF; Borrell Palanca A; Giner Marco V; Esteve Claramunt J; Pastor Sempere F
Arch Esp Urol; 2004; 57(1):35-40. PubMed ID: 15112869
[TBL] [Abstract][Full Text] [Related]
30. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing?
Dunst J
Strahlenther Onkol; 2004 Nov; 180(11):671-81. PubMed ID: 15549184
[TBL] [Abstract][Full Text] [Related]
31. Anaemia in cancer: pathophysiology and treatment.
Mercadante S; Gebbia V; Marrazzo A; Filosto S
Cancer Treat Rev; 2000 Aug; 26(4):303-11. PubMed ID: 10913385
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin-stimulating agents in oncology.
Savona MR; Silver SM
Cancer J; 2008; 14(2):75-84. PubMed ID: 18391611
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin.
Lambert KE
Can Nurse; 1990 Nov; 86(10):27-8. PubMed ID: 2224810
[No Abstract] [Full Text] [Related]
34. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
35. Is it necessary to check outcomes to improve quality of care? The example of anemia management.
Di Benedetto A; Richards N; Marcelli D; Basci A; Cesare S; Ponce P; Scatizzi L; Marotta P
J Nephrol; 2008; 21 Suppl 13():S146-52. PubMed ID: 18446749
[TBL] [Abstract][Full Text] [Related]
36. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
38. The management of cancer anemia.
Henry DH
Support Care Cancer; 1994 Nov; 2(6):403-4. PubMed ID: 7858936
[TBL] [Abstract][Full Text] [Related]
39. Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO.
Brandberg Y
Med Oncol; 2000 Nov; 17 Suppl 1():S23-31. PubMed ID: 11188783
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
van Kaam AH; Egeler RM
Cancer; 1996 Sep; 78(5):1144-5. PubMed ID: 8780558
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
